What stocks does Mirae Asset Healthcare Fund Direct Growth hold?

Mirae Asset Healthcare Fund Direct Growth holds a portfolio of Indian equity stocks disclosed monthly by Mirae Asset Mutual Fund to AMFI. The complete current holdings with weights and month-over-month changes are available on this page. Data is sourced from official AMFI portfolio disclosures.

Which AMC manages Mirae Asset Healthcare Fund Direct Growth?

Mirae Asset Healthcare Fund Direct Growth is managed by Mirae Asset Mutual Fund, a SEBI-registered Asset Management Company in India.

What category is Mirae Asset Healthcare Fund Direct Growth?

Mirae Asset Healthcare Fund Direct Growth is classified as a Equity mutual fund under SEBI's mutual fund categorisation framework.

How often is Mirae Asset Healthcare Fund Direct Growth portfolio data updated?

Portfolio holdings for Mirae Asset Healthcare Fund Direct Growth are updated monthly. SEBI mandates all AMCs to disclose their complete portfolio within 10 days of each month end. RightAdvise sources this data directly from official AMFI portfolio disclosures.

← Mirae Asset Mutual Fund

Mirae Asset Healthcare Fund Direct Growth

Equity Data as of May 2026 Comparing Apr 2026 → May 2026

Share: WhatsApp X

Stocks Held

May 2026

Equity Holdings

₹3,070.59 Cr

Equity only, excl. debt & cash

Top 5 Weight

38.1%

Moderate

Top 10 Weight

59.0%

Moderate

Changes

0 new · 3 exits

Top Sector

Pharmaceuticals & Biotechnology

75.5% of portfolio

📋 What Happened This Month Mirae Asset Healthcare Fund Direct Growth exited 3 stocks from its portfolio this month. Wockhardt Limited was the biggest exit (Pharmaceuticals & Biotechnology), which was held at 0.10%. Among existing holdings, Laurus Labs Limited saw the biggest increase — now at 4.35% of the portfolio. Glenmark Pharmaceuticals Limited was trimmed the most, now at 6.40%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 75.5%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.

How Has the NAV Performed?

1 year history · Mirae Asset Healthcare Fund Direct Growth

+1.64%

+12.53%

+13.16%

+15.78%

Latest NAV

₹48.56

24 Jun 2026

52W High

₹48.56

At High

52W Low

₹37.13

+31% from Low

Calendar Year Returns

Jan 1 to Dec 31 each year. Simple point-to-point — not CAGR.

2025

-2.0%

2024

+41.2%

2023

+36.1%

2022

-10.5%

2021

+28.6%

2020

+76.8%

2019

+8.1%

Rolling Returns

Performance across every possible investment start date.

1Y Rolling Avg

26.0%

+ve in 81% windows

92.0% / -10.5%

3Y Rolling Avg

24.1% p.a.

+ve in 100% windows

36.4% / 13.3%

5Y Rolling Avg

24.8% p.a.

+ve in 100% windows

34.1% / 15.8%

Crisis Period Behaviour

"Pre-inception" = fund didn't exist during that period.

2024–25 Tariff

-15.9%

Rec: Jul 2025 (7 mo)

COVID-19 Crash

-20.0%

Rec: Apr 2020 (1 mo)

2022 Rate Hike

-17.4%

Rec: Jun 2023 (1yr 6mo)

2018 IL&FS

-10.9%

Rec: Jan 2020 (1yr 9mo)

Risk Ratios

3 years daily NAV · Risk-free rate 6.5% p.a. What do these mean? →

Sharpe Ratio (3Y)

1.56

Return per unit of risk. >1 is good.

Sortino Ratio (3Y)

2.28

Penalises downside volatility only.

Std Deviation (3Y)

14.0%

Lower = more consistent returns.

NAV Chart ₹48.56 24 Jun 2026

Simple Moving Avg: Click to draw · click again to remove

Mirae Asset Healthcare Fund Direct Growth

Chart shows indexed performance (base = 100). Actual NAV: ₹48.56

Sector Shift Industry allocation month-over-month

Mar 2026 → Apr 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	77.7%	76.6%	▼ -1.1%
Healthcare Services	20.8%	22.2%	▲ +1.4%
Chemicals & Petrochemicals	0.9%	1.1%	▲ +0.3%
IT - Services	0.5%	0.0%	▼ -0.5%

Apr 2026 → May 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	76.6%	75.5%	▼ -1.1%
Healthcare Services	22.2%	22.8%	▲ +0.6%
Chemicals & Petrochemicals	1.1%	1.1%	● +0.0%

🔴

Biggest Exit

Wockhardt Limited

0.10% was held · Pharmaceuticals & Biotechnology

↑

Biggest Add

Laurus Labs Limited

+0.65% · now 4.35%

↓

Biggest Trim

Glenmark Pharmaceuticals Limited

-0.72% · now 6.40%

👋 Other funds also exited

Syngene International Limited 6 funds

Wockhardt Limited 1 fund

What Changed in the Portfolio This Month?

Comparing Apr 2026 → May 2026

Apr 2026 → May 2026

🔴 3 Exits ↑ 14 Increased ↓ 14 Decreased

#	Stock	Sector	Last Weight (Apr 2026)
1	Wockhardt Limited ₹3.04 Cr	Pharmaceuticals & Biotechnology	0.10%
2	Rubicon Research Limited ₹2.98 Cr	Pharmaceuticals & Biotechnology	0.10%
3	Syngene International Limited ₹10.20 L	Healthcare Services	0.00%

#	Stock	Sector	Apr 2026	May 2026	Change
1	Laurus Labs Limited ₹134.53 Cr	Pharmaceuticals & Biotechnology	3.70%	4.35%	+0.65%
2	Dr. Lal Path Labs Limited ₹78.52 Cr	Healthcare Services	1.99%	2.54%	+0.55%
3	Gland Pharma Limited ₹68.79 Cr	Pharmaceuticals & Biotechnology	1.82%	2.23%	+0.41%
4	Mankind Pharma Limited ₹64.01 Cr	Pharmaceuticals & Biotechnology	1.75%	2.07%	+0.32%
5	Eris Lifesciences Limited ₹100.35 Cr	Pharmaceuticals & Biotechnology	2.96%	3.25%	+0.29%
6	Krishna Institute Of Medical Sciences Limited ₹109.67 Cr	Healthcare Services	3.28%	3.55%	+0.27%
7	Apollo Hospitals Enterprise Limited ₹186.67 Cr	Healthcare Services	5.93%	6.04%	+0.11%
8	Sai Life Sciences Limited ₹99.68 Cr	Pharmaceuticals & Biotechnology	3.13%	3.23%	+0.10%
9	JB Chemicals & Pharmaceuticals Limited ₹199.26 Cr	Pharmaceuticals & Biotechnology	6.39%	6.45%	+0.06%
10	Alkem Laboratories Limited ₹110.45 Cr	Pharmaceuticals & Biotechnology	3.51%	3.57%	+0.06%
11	Cipla Limited ₹99.28 Cr	Pharmaceuticals & Biotechnology	3.16%	3.21%	+0.05%
12	Neogen Chemicals Limited ₹19.13 Cr	Chemicals & Petrochemicals	0.57%	0.62%	+0.05%
13	Onesource Specialty Pharma Limited ₹100.60 Cr	Pharmaceuticals & Biotechnology	3.22%	3.26%	+0.04%
14	Narayana Hrudayalaya Limited ₹41.23 Cr	Healthcare Services	1.31%	1.33%	+0.02%

#	Stock	Sector	Apr 2026	May 2026	Change
1	Glenmark Pharmaceuticals Limited ₹197.78 Cr	Pharmaceuticals & Biotechnology	7.12%	6.40%	-0.72%
2	Sun Pharmaceutical Industries Limited ₹344.03 Cr	Pharmaceuticals & Biotechnology	11.76%	11.13%	-0.63%
3	Biocon Limited ₹17.35 Cr	Pharmaceuticals & Biotechnology	1.19%	0.56%	-0.63%
4	Lupin Limited ₹132.13 Cr	Pharmaceuticals & Biotechnology	4.57%	4.28%	-0.29%
5	Divi's Laboratories Limited ₹248.13 Cr	Pharmaceuticals & Biotechnology	8.23%	8.03%	-0.20%
6	Fortis Healthcare Limited ₹120.06 Cr	Healthcare Services	4.06%	3.88%	-0.18%
7	Dr. Reddy's Laboratories Limited ₹131.94 Cr	Pharmaceuticals & Biotechnology	4.44%	4.27%	-0.17%
8	Aster DM Healthcare Limited ₹95.73 Cr	Healthcare Services	3.23%	3.10%	-0.13%
9	Sudeep Pharma Limited ₹11.45 Cr	Pharmaceuticals & Biotechnology	0.48%	0.37%	-0.11%
10	Aurobindo Pharma Limited ₹127.28 Cr	Pharmaceuticals & Biotechnology	4.22%	4.12%	-0.10%
11	Max Healthcare Institute Limited ₹72.53 Cr	Healthcare Services	2.43%	2.35%	-0.08%
12	Anthem Biosciences Limited ₹37.08 Cr	Pharmaceuticals & Biotechnology	1.26%	1.20%	-0.06%
13	Deepak Nitrite Limited ₹15.40 Cr	Chemicals & Petrochemicals	0.54%	0.50%	-0.04%
14	IPCA Laboratories Limited ₹93.35 Cr	Pharmaceuticals & Biotechnology	3.03%	3.02%	-0.01%

What Stocks Does This Fund Hold?

29 stocks — May 2026

#	Stock	Sector	Weight & Value
1	Sun Pharmaceutical Industries Limited ₹344.03 Cr	Pharmaceuticals & Biotechnology	11.13%
2	Divi's Laboratories Limited ₹248.13 Cr	Pharmaceuticals & Biotechnology	8.03%
3	JB Chemicals & Pharmaceuticals Limited ₹199.26 Cr	Pharmaceuticals & Biotechnology	6.45%
4	Glenmark Pharmaceuticals Limited ₹197.78 Cr	Pharmaceuticals & Biotechnology	6.40%
5	Apollo Hospitals Enterprise Limited ₹186.67 Cr	Healthcare Services	6.04%
6	Laurus Labs Limited ₹134.53 Cr	Pharmaceuticals & Biotechnology	4.35%
7	Lupin Limited ₹132.13 Cr	Pharmaceuticals & Biotechnology	4.28%
8	Dr. Reddy's Laboratories Limited ₹131.94 Cr	Pharmaceuticals & Biotechnology	4.27%
9	Aurobindo Pharma Limited ₹127.28 Cr	Pharmaceuticals & Biotechnology	4.12%
10	Fortis Healthcare Limited ₹120.06 Cr	Healthcare Services	3.88%
11	Alkem Laboratories Limited ₹110.45 Cr	Pharmaceuticals & Biotechnology	3.57%
12	Krishna Institute Of Medical Sciences Limited ₹109.67 Cr	Healthcare Services	3.55%
13	Onesource Specialty Pharma Limited ₹100.60 Cr	Pharmaceuticals & Biotechnology	3.26%
14	Eris Lifesciences Limited ₹100.35 Cr	Pharmaceuticals & Biotechnology	3.25%
15	Sai Life Sciences Limited ₹99.68 Cr	Pharmaceuticals & Biotechnology	3.23%
16	Cipla Limited ₹99.28 Cr	Pharmaceuticals & Biotechnology	3.21%
17	Aster DM Healthcare Limited ₹95.73 Cr	Healthcare Services	3.10%
18	IPCA Laboratories Limited ₹93.35 Cr	Pharmaceuticals & Biotechnology	3.02%
19	Dr. Lal Path Labs Limited ₹78.52 Cr	Healthcare Services	2.54%
20	Max Healthcare Institute Limited ₹72.53 Cr	Healthcare Services	2.35%
21	Gland Pharma Limited ₹68.79 Cr	Pharmaceuticals & Biotechnology	2.23%
22	Mankind Pharma Limited ₹64.01 Cr	Pharmaceuticals & Biotechnology	2.07%
23	Narayana Hrudayalaya Limited ₹41.23 Cr	Healthcare Services	1.33%
24	Anthem Biosciences Limited ₹37.08 Cr	Pharmaceuticals & Biotechnology	1.20%
25	Neogen Chemicals Limited ₹19.13 Cr	Chemicals & Petrochemicals	0.62%
26	Biocon Limited ₹17.35 Cr	Pharmaceuticals & Biotechnology	0.56%
27	Deepak Nitrite Limited ₹15.40 Cr	Chemicals & Petrochemicals	0.50%
28	Torrent Pharmaceuticals Limited ₹14.20 Cr	Pharmaceuticals & Biotechnology	0.46%
29	Sudeep Pharma Limited ₹11.45 Cr	Pharmaceuticals & Biotechnology	0.37%